Heart Test Laboratories I...

NASDAQ: HSCS · Real-Time Price · USD
3.37
-0.13 (-3.71%)
At close: Aug 15, 2025, 3:59 PM
3.38
0.30%
After-hours: Aug 15, 2025, 05:13 PM EDT

Heart Test Laboratories Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021
Revenue
4.35K n/a 14.7K 18.6K 18.6K 5.16M 5.15M 5.15M 5.15M 9.3K 10.09K 10.09K 14.37K 25.17K 22.43K 22.43K 14.95K
Cost of Revenue
1.88K 9.2K 85.21K 52.32K 26.34K 2.81M 2.8M 2.81M 2.8M 10.89K 10.98K 10.77K 14.49K 19.43K 18.58K 11.98K 6.22K
Gross Profit
2.47K -9.2K -70.51K -33.72K -7.74K 2.35M 2.35M 2.34M 2.35M -1.59K -894 -682 -118 5.74K 3.86K 10.46K 8.73K
Operating Income
-2.38B -2.38B -7.47M -7.05M -6.31M -6.02M -5.81M -6.01M -6.11M -6.49M -6.28M -5.47M -4.71M -3.52M -2.42M -1.46M -786.24K
Interest Income
14.66K 14.66K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-2.54B -2.54B -7.62M -7.29M -6.61M -6.39M -6.09M -6.15M -6.35M -6.78M -6.67M -5.9M -4.83M -3.63M -2.39M -1.35M -851.57K
Net Income
-2.54B -2.54B -7.62M -7.29M -6.61M -6.43M -6.16M -6.25M -6.6M -7.06M -6.92M -6.12M -4.9M -3.63M -2.39M -1.35M -851.57K
Selling & General & Admin
1.34B 1.34B 3.49M 3.52M 3.44M 3.67M 3.31M 3.42M 3.65M 3.22M 2.95M 2.44M 1.71M 1.29M 888.21K 477.13K 202.07K
Research & Development
1.04B 1.04B 3.98M 3.54M 2.88M 2.37M 2.5M 2.59M 2.46M 3.28M 3.34M 3.03M 3M 2.24M 1.54M 995.1K 593.99K
Other Expenses
-2.37B -2.37B 16.00 19.00 79.00 334.00 311.00 1.51K 1.85K 3.3K 4.16K 2.96K 2.56K -368 -1.22K -1.22K -1.22K
Operating Expenses
8.32M 8.28M 7.44M 7.03M 6.31M 6.03M 5.81M 6.01M 6.12M 6.5M 6.29M 5.47M 4.72M 3.53M 2.43M 1.47M 796.06K
Interest Expense
500.45K 340.54K 279.51K 340.35K 354.08K 367.1K 281.46K 135.83K 243.17K 286.25K 392.51K 437.62K 371.62K 358.7K 219.63K 141.72K 64.12K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
8.36M 8.31M 7.48M 7.07M 6.32M 6.04M 5.81M 6.02M 6.12M 6.5M 6.29M 5.48M 4.72M 3.54M 2.44M 1.48M 802.28K
Income Tax Expense
n/a n/a 3.00 3.00 3.00 34.22K 67.02K 98.63K 241.84K 282.95K 250.14K 218.53K 75.33K n/a n/a n/a n/a
Shares Outstanding (Basic)
1.11M 986.06K 917.45K 777.75K 676.6K 537.93K 109.39K 103.32K 101.18K 83.5K 82.11K 56.19K 33.24K 33.23K 33.14K 33.14K 33.14K
Shares Outstanding (Diluted)
1.11M 986.06K 917.45K 777.75K 676.6K 537.93K 109.39K 103.32K 101.18K 83.5K 82.11K 56.45K 33.24K 33.23K 33.14K 33.14K 33.14K
EPS (Basic)
-9.36 -10.21 -10.7 -24.41 -35 -48.74 -62.15 -68.56 -85.88 -133.45 -154.25 -163.09 -147.68 -109.34 -72.07 -40.84 -25.7
EPS (Diluted)
-9.36 -10.21 -10.7 -24.41 -35 -48.74 -62.15 -68.56 -85.74 -133.3 -154.1 -162.94 -147.67 -109.34 -72.07 -40.84 -25.7
EBITDA
-1.99B -1.99B -1.99B -6.9M -6.22M -6M -5.78M -5.98M -6.08M -6.46M -6.25M -5.44M -4.43M -3.24M -2.15M -1.2M -780.21K
EBIT
-8.26M -8.18M -7.35M -6.95M -6.25M -6.02M -5.81M -6.01M -6.11M -6.49M -6.28M -5.46M -4.46M -3.27M -2.17M -1.21M -787.46K
Depreciation & Amortization
-1.98B -1.98B -1.98B 121.11K 95.13K 25.52K 28.66K 27.84K 26.91K 26.59K 26.22K 26K 26.57K 27.32K 20.83K 14.22K 7.25K